4.5 Review

Germline predisposition to hematopoietic malignancies

Related references

Note: Only part of the references are listed.
Article Hematology

Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes

Piers Blombery et al.

Summary: Accurate diagnostic categorization is crucial for patients with bone marrow failure (BMF), and genomic characterization plays a critical role in providing important diagnostic and prognostic information. The study revealed that genomic characterization resulted in a change of diagnosis in 26% of patients, highlighting the impact on treatment decisions and disease management. Multiple novel pathogenic variants were identified, emphasizing the importance of routine genomic characterization in this patient population.

HAEMATOLOGICA (2021)

Article Genetics & Heredity

Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies

Gregory W. Roloff et al.

Summary: There is a high degree of diagnostic heterogeneity among commercially available diagnostic assays for hereditary hematopoietic malignancies (HHMs). Many assays are unable to detect the full spectrum of HHM-associated variants, which may lead to underdiagnosis, missed opportunities for screening, and potential donor-derived malignancies. The assays vary in price, number of genes sequenced, turnaround time, and sensitivity for relevant structural alterations.

GENETICS IN MEDICINE (2021)

Article Hematology

Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency

Anfeng Mu et al.

Summary: A novel Fanconi anemia-like inherited bone marrow failure syndrome has been discovered in Japanese children and is associated with variants in the ADH5 and ALDH2 genes. ADH5 is identified as the primary defense against formaldehyde, with ALDH2 providing a backup mechanism. Patient-derived fibroblasts displayed normal levels of DNA repair, whereas disease model iPSCs showed defective cell expansion during hematopoietic differentiation in vitro, which could be partially reversed by treatment with a new small molecule called C1.

BLOOD (2021)

Review Oncology

Revertant somatic mosaicism as a cause of cancer

Toshiya Inaba et al.

Summary: Revertant (somatic) mosaicism is a spontaneous correction of a causative mutation in patients with congenital diseases, which may bring favorable outcomes. However, in certain conditions, overcorrection can lead to serious consequences.

CANCER SCIENCE (2021)

Article Medicine, Research & Experimental

Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency

Bethany A. Pillay et al.

Summary: Inborn errors of immunity can lead to monogenic immune dysregulatory conditions, and somatic reversion can improve clinical symptoms, including complete resolution of infections and allergic diseases. Acquisition of DOCK8 expression can restore lymphocyte signaling and cell function, which is significant for the treatment of DOCK8 deficiency.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Letter Oncology

Germline variants drive myelodysplastic syndrome in young adults

Simone Feurstein et al.

LEUKEMIA (2021)

Editorial Material Hematology

Endogenous formaldehyde destroys blood stem cells

Moonjung Jung et al.

Summary: The study demonstrates that iPSCs derived from patients with ADH5/ALDH2 deficiency fail to generate hematopoietic progenitors.

BLOOD (2021)

Article Oncology

Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer

Deepak Singhal et al.

Summary: The study found that 13% of patients with hematological malignancies and other independent cancers had pathogenic germline variants (PGVs), with the most common being in CHEK2, BRCA1, DDX41, and TP53. Screening for PGVs can be triggered by a history of multiple cancers.

LEUKEMIA (2021)

Letter Hematology

In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation

Catherine Hockings et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Review Hematology

Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity

Elina K. Cook et al.

EXPERIMENTAL HEMATOLOGY (2020)

Article Immunology

Progressive B Cell Loss in Revertant X-SCID

Connie H. Lin et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans

Felix A. Dingler et al.

MOLECULAR CELL (2020)

Editorial Material Hematology

Accurate germline RUNX1 variant interpretation and its clinical significance

Simone Feurstein et al.

BLOOD ADVANCES (2020)

Article Hematology

Hereditary myeloid malignancies

Hind Rafei et al.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2019)

Review Hematology

Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia

Pallavi Galera et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2019)

Article Multidisciplinary Sciences

Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia

Gayle P. Pouliot et al.

PLOS ONE (2019)

Article Multidisciplinary Sciences

Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host

Marlies Meisel et al.

NATURE (2018)

Correction Multidisciplinary Sciences

Diagnostic utility of telomere length testing in a hospital-based setting (vol 115, pg E2358, 2018)

Jonathan K. Alder et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

Diagnostic utility of telomere length testing in a hospital-based setting

Jonathan K. Alder et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Oncology

Myelodysplastic Syndromes, Version 2.2017 Clinical Practice Guidelines in Oncology

Peter L. Greenberg et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)

Article Biochemistry & Molecular Biology

Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage

Yasmine Zerdoumi et al.

HUMAN MOLECULAR GENETICS (2017)

Article Hematology

Germline ETV6 mutations and predisposition to hematological malignancies

Simone Feurstein et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)

Article Medicine, Research & Experimental

Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans

Federica Buonocore et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Hematology

ETV6 in hematopoiesis and leukemia predisposition

Hanno Hock et al.

SEMINARS IN HEMATOLOGY (2017)

Review Hematology

Role of RUNX1 in hematological malignancies

Raman Sood et al.

BLOOD (2017)

Article Genetics & Heredity

Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L

Dong-Hui Chen et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2016)

Article Oncology

Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms

Chantana Polprasert et al.

CANCER CELL (2015)

Article Critical Care Medicine

Exome Sequencing Identifies Mutant TINF2 in a Family With Pulmonary Fibrosis

Jonathan K. Alder et al.

CHEST (2015)

Article Biochemistry & Molecular Biology

AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia

Elizabeth L. Virts et al.

HUMAN MOLECULAR GENETICS (2015)

Article Oncology

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers

Gaelle Bougeard et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Genetics & Heredity

Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies

Joseph Saliba et al.

NATURE GENETICS (2015)

Article Genetics & Heredity

Germ line ETV6 mutations in familial thrombocytopenia and hematologic malignancy

Michael Y. Zhang et al.

NATURE GENETICS (2015)

Review Hematology

Bone marrow failure and the telomeropathies

Danielle M. Townsley et al.

BLOOD (2014)

Article Genetics & Heredity

Exome Sequencing Identifies Autosomal-Dominant SRP72 Mutations Associated with Familial Aplasia and Myelodysplasia

Michael Kirwan et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2012)

Article Genetics & Heredity

Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations

Richard H. Scott et al.

JOURNAL OF MEDICAL GENETICS (2007)

Article Health Care Sciences & Services

The frustrations of families: Henry Lynch, heredity, and cancer control, 1962-1975

David Cantor

MEDICAL HISTORY (2006)

Article Medicine, General & Internal

Brief report - Mutation of CEBPA in familial acute myeloid leukemia

ML Smith et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Letter Genetics & Heredity

Early-onset brain tumor and lymphoma in MSH2-deficient children

L Bougeard et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2003)